Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In November 2023, AstraZeneca and Eccogene made an exclusive deal for ECC5004, a promising oral medication taken once daily that acts as a glucagon-like peptide 1 receptor agonist (GLP-1RA)
BPC-157 Thymosin Beta 4 may improve nervous system health by decreasing inflammation and oxidative stress, protecting neurons, and encouraging tissue repair and cell migration
Molecules 25 (22), 5342
In a study published in May, researchers used a large patient dataset to compare the NAION rate within 1 year of adults with Type 2 diabetes starting GLP-1 treatment (like Ozempic) versus those starting dipeptidyl peptidase 4 inhibitors
Clinical context matters
US$ 26.83
US$ 22.69
US$ 25.06
US$ 22.64
US$ 21.41
US$ 28.76
